A Phase II Study of Bryostatin-1 (NSC 339555) Plus Paclitaxel in Patients With Metastatic or Unresectable Locally Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction.
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2012
At a glance
- Drugs Bryostatin-1 (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 03 Aug 2010 Actual end date (Sep 2005) added as reported by ClinicalTrials.gov.
- 03 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Oct 2005 New trial record.